More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana, Inc. CEO Featured by Reuters, U.S. News & World Report, and More on Status of Marijuana Banking

Medical Marijuana, Inc. CEO Featured by Reuters, U.S. News & World Report, and More on Status of Marijuana Banking

by adminAdrianRamirez | Jan 2, 2018 | Media Coverage

Limits to marijuana banking services is trending in the national media this week with article featuring Medical Marijuana, Inc. executive. Dr. Stuart Titus, President and CEO of Medical Marijuana, Inc. was featured as part of an article published recently by Reuters...
Medical Marijuana, Inc. Announces Promotion of Vice President of Operations Blake N. Schroeder, Esq., to Chief Operating Officer

Medical Marijuana, Inc. Announces Promotion of Vice President of Operations Blake N. Schroeder, Esq., to Chief Operating Officer

by adminAdrianRamirez | Dec 19, 2017 | Press Releases

SAN DIEGO, Dec. 19, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its Vice President of Operations, Blake N. Schroeder, Esq., has been promoted to Chief Operating Officer....
International Publications Spotlight MJNA’s Influence on U.N.’s Global CBD Policy Announcement

International Publications Spotlight MJNA’s Influence on U.N.’s Global CBD Policy Announcement

by adminAdrianRamirez | Dec 19, 2017 | Media Coverage

Following the WHO’s announcement of its stance that CBD not be considered a drug, several news reports covering the event highlighted MJNA’s role in the organization’s decision. Several international news publications covering last week’s World Health Organization...
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces International News Coverage on Benefits of CBD, U.N.’s Global CBD Policy

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces International News Coverage on Benefits of CBD, U.N.’s Global CBD Policy

by adminAdrianRamirez | Dec 18, 2017 | HempMeds Mexico, Press Releases

SAN DIEGO, Dec. 18, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that Raúl Elizalde, President of subsidiary HempMeds® Mexico, was recently featured in several international news...
United Nations Makes Recommendation Not To Schedule CBD as Drug After Medical Marijuana, Inc. Executive Spoke at World Health Organization Convention

United Nations Makes Recommendation Not To Schedule CBD as Drug After Medical Marijuana, Inc. Executive Spoke at World Health Organization Convention

by adminAdrianRamirez | Dec 14, 2017 | Press Releases

HempMeds® Mexico President Raúl Elizalde Influences Global Policy Recommendation SAN DIEGO, Dec. 14, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that the World...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.